Anti-cancer potential of rencofilstat expanded with results from preclinical multiple myeloma studies

- synergistic activity demonstrated with rencofilstat in combination with first line multiple myeloma drug, bortezomib -

HEPA Ratings Summary

HEPA Quant Ranking